Cardiofaciocutaneous syndrome
Cardiofaciocutaneous syndrome Causes
CFC is said to be a cause of a biochemical relational of mutated genes, particularly those found in BRAF and KRAS, MEK1 and MEK2 genes.
Cardiofaciocutaneous syndrome Definition
Cardiofaciocutaneous syndrome is a congenital anomaly characterized by mental retardation and marked with heart defects, ectodermal abnormalities as well as growth failure. This medical condition was first discovered in 1986, and to date, there are less than 300 recorded cases of this congenital disorder all over the world, and known to affect both sexes across all ethnic background.
Cardiofaciocutaneous syndrome Diagnosis
The diagnosis of CFC syndrome is made through observations made of the known features and symptoms of the syndrome. Magnetic resonance imaging or MRI may be used to produce ultrasound imaging of the brain and heart to provide a more definitive diagnosis.
Cardiofaciocutaneous syndrome Symptoms and Signs
The cardiofaciocutaneous syndrome is characterized by heart defects, sparse and brittle scalp hair, delayed growth, psychomotor retardation, foot abnormalities, heart malformations, and distinctive facial appearance.
Cardiofaciocutaneous syndrome Treatment
The CFC syndrome has no existing cure and treatment available. Therapies available today are purely symptomatic for symptoms of the syndrome that affects the individual. Skin care help, special education and speech therapy are among the most common treatments available. For patients suffering from tube feeding and heart defects, surgical intervention is the available option.